Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new history entry for version 1016 on 2026-07-02 with revision v3.6.3 was added to the study's history, including Contacts/Locations and Study Status in the record; the prior entry dated 2026-06-15 with revision v3.6.2 was removed.SummaryDifference0.0%

- Check16 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous Revision: v3.6.0.SummaryDifference0.0%

- Check23 days agoChange DetectedA new history entry (version 1015) was added on 2026-06-15, including updated Study Status and new Contacts/Locations in the study record.SummaryDifference0.0%

- Check32 days agoChange DetectedThe history now includes a note that the study is no longer looking for participants and the record has been updated to Revision: v3.6.0. The older Revision: v3.5.5 was removed.SummaryDifference0.0%

- Check39 days agoChange DetectedVersion 1014 (Revision: v3.5.5) was added on 2026-05-28. On 2026-05-29, Contacts/Locations and Study Status were updated within that version, reflecting updated contact details and recruitment status in the study history.SummaryDifference0.0%

- Check53 days agoChange DetectedA new history entry dated 2026-05-13 notes updates to Arms and Interventions and Study Status (referencing 2026-05-12 and Revision: v3.5.4). The earlier 2026-05-01 entry and Revision: v3.5.3 were removed.SummaryDifference0.0%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.